O21: Medical problems in fragile X syndrome: FORWARD results from over 1400 participants age 0-21 with an FMR-1 full mutation*

by Nicole Tartaglia, Randi Hagerman, Elizabeth Berry-Kravis
Published 2023-01-01

Digital gait markers to potentially distinguish fragile X-associated tremor/ataxia syndrome, Parkinson’s disease, and essential tremor

by Erin E. Robertson-Dick, Emily C. Timm, Gian Pal, Bichun Ouyang, Yuanqing Liu, Elizabeth Berry-Kravis, Elizabeth Berry-Kravis, Elizabeth Berry-Kravis, Deborah A. Hall, Joan A. O’Keefe, Joan A. O’Keefe
Published 2023-12-01

Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome

by Elizabeth Berry-Kravis, Allison Sumis, Crystal Hervey, Shaguna Mathur
Published 2012-01-01

Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective

by Anna W. Lee, Pamela Ventola, Dejan Budimirovic, Elizabeth Berry-Kravis, Jeannie Visootsak
Published 2018-12-01

Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature

by Alexander Kolevzon, Elsa Delaby, Elizabeth Berry-Kravis, Joseph D. Buxbaum, Catalina Betancur
Published 2019-12-01

Delineating Repetitive Behavior Profiles across the Lifespan in Fragile X Syndrome

by Debra L. Reisinger, Rebecca C. Shaffer, Nicole Tartaglia, Elizabeth Berry-Kravis, Craig A. Erickson
Published 2020-04-01

Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities

by Jayne Dixon Weber, Elizabeth Smith, Elizabeth Berry-Kravis, Diego Cadavid, David Hessl, Craig Erickson
Published 2019-01-01

Language across the Lifespan in Fragile X Syndrome: Characteristics and Considerations for Assessment

by Anne Hoffmann, Angel Wang, Natalie Berger, Lisa Cordeiro, Rebecca Shaffer, Nicole Tartaglia, Craig Erickson, Elizabeth Berry-Kravis
Published 2020-04-01

Mortality in Women across the <i>FMR1</i> CGG Repeat Range: The Neuroprotective Effect of Higher Education

by Jinkuk Hong, Robert S. Dembo, Leann Smith DaWalt, Mei Wang Baker, Elizabeth Berry-Kravis, Marsha R. Mailick
Published 2023-08-01

Potential Prodromal Digital Postural Sway Markers for Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) Detected via Dual-Tasking and Sensory Manipulation

by Emily C. Timm, Nicollette L. Purcell, Bichun Ouyang, Elizabeth Berry-Kravis, Deborah A. Hall, Joan Ann O’Keefe
Published 2024-04-01

Effects of mavoglurant on visual attention and pupil reactivity while viewing photographs of faces in Fragile X Syndrome.

by David Hessl, Danielle Harvey, Stephanie Sansone, Crystal Crestodina, Jamie Chin, Reshma Joshi, Randi J Hagerman, Elizabeth Berry-Kravis
Published 2019-01-01

A Unique Visual Attention Profile Associated With the FMR1 Premutation

by Molly Winston, Kritika Nayar, Emily Landau, Nell Maltman, John Sideris, Lili Zhou, Kevin Sharp, Elizabeth Berry-Kravis, Molly Losh
Published 2021-02-01

Abnormal neural sensitivity to rewards as a candidate process of high depression risk in the FMR1 premutation: A pilot study

by Roslyn Harold, Bridgette Kelleher, Keisha Novak, Wei Siong Neo, Teagan Stump, Taylor Lee, Tessa Garwood, Elizabeth Berry-Kravis, Dan Foti
Published 2024-06-01

Developmental associations between cognition and adaptive behavior in intellectual and developmental disability

by Andrew Dakopolos, Emma Condy, Elizabeth Smith, Danielle Harvey, Aaron J. Kaat, Jeanine Coleman, Karen Riley, Elizabeth Berry-Kravis, David Hessl
Published 2024-06-01

Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS).

by Deborah A Hall, Erin E Robertson, Maureen Leehey, Andrew McAsey, Bichun Ouyang, Elizabeth Berry-Kravis, Joan A O'Keefe
Published 2020-01-01

Health Profiles of Mosaic Versus Non-mosaic FMR1 Premutation Carrier Mothers of Children With Fragile X Syndrome

by Marsha R. Mailick, Arezoo Movaghar, Arezoo Movaghar, Jinkuk Hong, Jan S. Greenberg, Leann S. DaWalt, Lili Zhou, Lili Zhou, Jonathan Jackson, Paul J. Rathouz, Paul J. Rathouz, Mei W. Baker, Mei W. Baker, Murray Brilliant, Murray Brilliant, David Page, Elizabeth Berry-Kravis, Elizabeth Berry-Kravis
Published 2018-05-01

Utility of the Hebb–Williams Maze Paradigm for Translational Research in Fragile X Syndrome: A Direct Comparison of Mice and Humans

by Isabelle Boutet, Charles A. Collin, Lindsey S. MacLeod, Claude Messier, Matthew R. Holahan, Elizabeth Berry-Kravis, Reno M. Gandhi, Cary S. Kogan
Published 2018-03-01

Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from...

by Angela John Thurman, Jamie O. Edgin, Stephanie L. Sherman, Audra Sterling, Andrea McDuffie, Elizabeth Berry-Kravis, Debra Hamilton, Leonard Abbeduto
Published 2021-04-01

Tremorography in fragile X-associated tremor/ataxia syndrome, Parkinson's disease and essential tremor

by Erin E. Robertson, Deborah A. Hall, Gian Pal, Bichun Ouyang, Yuanqing Liu, Jessica M. Joyce, Elizabeth Berry-Kravis, Joan A. O'Keefe
Published 2020-01-01

The association between expressive language skills and adaptive behavior in individuals with Down syndrome

by Laura del Hoyo Soriano, Jennifer Catalina Villarreal, Audra Sterling, Jamie Edgin, Elizabeth Berry-Kravis, Debra R. Hamilton, Angela John Thurman, Leonard Abbeduto
Published 2022-11-01